Invesco Bloomberg Analyst Rating Improvers ETF (NYSEARCA:UPGD – Get Free Report) was the recipient of a significant decrease in short interest in the month of May. As of May 29th, there was short interest totaling 288 shares, a decrease of 94.3% from the May 14th total of 5,093 shares. Based on an average trading volume of 1,693 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the shares of the stock are short sold.
Invesco Bloomberg Analyst Rating Improvers ETF Stock Up 0.3%
NYSEARCA:UPGD traded up $0.25 during trading hours on Tuesday, reaching $81.46. The company had a trading volume of 559 shares, compared to its average volume of 2,612. The firm has a market capitalization of $118.12 million, a PE ratio of 20.47 and a beta of 0.92. The stock has a 50-day moving average of $77.43 and a two-hundred day moving average of $76.55. Invesco Bloomberg Analyst Rating Improvers ETF has a one year low of $69.16 and a one year high of $82.36.
Hedge Funds Weigh In On Invesco Bloomberg Analyst Rating Improvers ETF
A number of institutional investors and hedge funds have recently bought and sold shares of UPGD. Northwestern Mutual Wealth Management Co. boosted its stake in Invesco Bloomberg Analyst Rating Improvers ETF by 52,865.8% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 768,004 shares of the company’s stock worth $56,825,000 after purchasing an additional 766,554 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in Invesco Bloomberg Analyst Rating Improvers ETF by 85.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 26,578 shares of the company’s stock worth $1,966,000 after purchasing an additional 12,267 shares in the last quarter. Total Wealth Planning & Management Inc. acquired a new position in Invesco Bloomberg Analyst Rating Improvers ETF in the fourth quarter worth $431,000. Stifel Financial Corp acquired a new position in Invesco Bloomberg Analyst Rating Improvers ETF in the fourth quarter worth $251,000. Finally, HRT Financial LP raised its position in Invesco Bloomberg Analyst Rating Improvers ETF by 51.6% in the 4th quarter. HRT Financial LP now owns 9,026 shares of the company’s stock worth $667,000 after purchasing an additional 3,073 shares during the last quarter.
About Invesco Bloomberg Analyst Rating Improvers ETF
The Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) is an exchange-traded fund that is based on the Bloomberg ANR Improvers index. The fund tracks an equal-weighted index of large-and mid-cap US stocks that are identified to have the most improved consensus ratings based on analyst recommendations. UPGD was launched on May 19, 2006 and is issued by Invesco.
Recommended Stories
- Five stocks we like better than Invesco Bloomberg Analyst Rating Improvers ETF
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Invesco Bloomberg Analyst Rating Improvers ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Bloomberg Analyst Rating Improvers ETF and related companies with MarketBeat.com's FREE daily email newsletter.
